Golimumab is really a human monoclonal antibody administered once a month by subcutaneous injection. Although it's the same basic safety and efficacy profile to other TNFi, golimumab is significantly less helpful than other TNFi in individuals who have unsuccessful a number of biological solutions.Guard your properly-staying with the correct immuni